Meanwhile, numerous studies have shown that compared with normal controls, a variety of tumor cells, such as liver cancer, lung cancer, melanoma, colorectal cancer and prostate cancer, exhibit significantly increased expression of ASCT2 [9–13]. This evidence concerns the gene SLC1A5 and prostate carcinoma.